Nearly 10–20% of MG patients are seronegative for Acetylcholine Receptor Antibody (AChR-Ab), and several studies have found that 20–40% of these AChR-Ab negative patients in the United States test positive for MuSK Ab [1–3]. This evidence concerns the gene MUSK and myasthenia gravis.